BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1337461)

  • 21. Baculovirus multigene expression vectors and their use for understanding the assembly process of architecturally complex virus particles.
    Roy P; Mikhailov M; Bishop DH
    Gene; 1997 Apr; 190(1):119-29. PubMed ID: 9185857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetically engineered multi-component virus-like particles as veterinary vaccines.
    Pearson LD; Roy P
    Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():381-9. PubMed ID: 8270267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins.
    Loudon PT; Roy P
    Virology; 1991 Feb; 180(2):798-802. PubMed ID: 1846500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A.
    Hyatt AD; Zhao Y; Roy P
    Virology; 1993 Apr; 193(2):592-603. PubMed ID: 8384747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype.
    Mertens PP; Pedley S; Cowley J; Burroughs JN; Corteyn AH; Jeggo MH; Jennings DM; Gorman BM
    Virology; 1989 Jun; 170(2):561-5. PubMed ID: 2543130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses.
    Loudon PT; Hirasawa T; Oldfield S; Murphy M; Roy P
    Virology; 1991 Jun; 182(2):793-801. PubMed ID: 1850928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-D reconstruction of bluetongue virus tubules using cryoelectron microscopy.
    Hewat EA; Booth TF; Wade RH; Roy P
    J Struct Biol; 1992; 108(1):35-48. PubMed ID: 1314066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytoreovirus T = 1 core plays critical roles in organizing the outer capsid of T = 13 quasi-equivalence.
    Wu B; Hammar L; Xing L; Markarian S; Yan J; Iwasaki K; Fujiyoshi Y; Omura T; Cheng RH
    Virology; 2000 May; 271(1):18-25. PubMed ID: 10814566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between bluetongue virus core and capsid proteins translated in vitro.
    Liu HM; Booth TF; Roy P
    J Gen Virol; 1992 Oct; 73 ( Pt 10)():2577-84. PubMed ID: 1328473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the genes encoding two of the major capsid proteins of epizootic haemorrhagic disease virus indicates a close genetic relationship to bluetongue virus.
    Iwata H; Chuma T; Roy P
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():915-24. PubMed ID: 1321879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterologous prime boost vaccination with DNA and recombinant modified vaccinia virus Ankara protects IFNAR(-/-) mice against lethal bluetongue infection.
    Calvo-Pinilla E; Rodríguez-Calvo T; Sevilla N; Ortego J
    Vaccine; 2009 Dec; 28(2):437-45. PubMed ID: 19857449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of virus inclusion bodies in bluetongue virus-infected cells.
    Brookes SM; Hyatt AD; Eaton BT
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():525-30. PubMed ID: 8383185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural studies on orbivirus proteins and particles.
    Stuart DI; Grimes JM
    Curr Top Microbiol Immunol; 2006; 309():221-44. PubMed ID: 16909901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural studies of orbivirus particles.
    Stuart DI; Gouet P; Grimes J; Malby R; Diprose J; Zientara S; Burroughs JN; Mertens PP
    Arch Virol Suppl; 1998; 14():235-50. PubMed ID: 9785510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression and characterization of two outer capsid proteins VP2 and VP5 of bluetongue virus in insect cells].
    Wang J; Jiang H; Qu J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Dec; 13(4):321-4. PubMed ID: 12759967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
    Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
    J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.
    Cowley JA; Gorman BM
    Vet Microbiol; 1989 Jan; 19(1):37-51. PubMed ID: 2466366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolutionary relationships among the gnat-transmitted orbiviruses that cause African horse sickness, bluetongue, and epizootic hemorrhagic disease as evidenced by their capsid protein sequences.
    Iwata H; Yamagawa M; Roy P
    Virology; 1992 Nov; 191(1):251-61. PubMed ID: 1329319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic relationships of bluetongue virus serotypes isolated from different parts of the world.
    Ritter DG; Roy P
    Virus Res; 1988 Aug; 11(1):33-47. PubMed ID: 2845682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.